ACOG issues statement on the benefit of access to SSRIs during pregnancy

The American College of Obstetricians and Gynaecologists have issued a statement describing the benefits of ensuring pregnant women have adequate access to SSRI antidepressants during pregnancy. The statement (available here) was issued in response to a panel discussion held by the U.S. Food and Drug Administration (FDA) which aired on Monday 21st July.